Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle

Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I

(2017) Marielle Brockhoff et al.   JOURNAL OF CLINICAL INVESTIGATION

Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1

(2015) S. Iachettini et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5

(2015) Karlie Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy

(2015) R Cardani et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2

(2014) Rosanna Cardani et al.   NEUROMUSCULAR DISORDERS

Splicing biomarkers of disease severity in myotonic dystrophy

(2013) Masayuki Nakamori et al.   ANNALS OF NEUROLOGY

Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2

(2013) Massimo Santoro et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2

(2013) Rosanna Cardani et al.   PLoS One

Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy

(2013) Z. Gao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Altered Ca2+ Homeostasis and Endoplasmic Reticulum Stress in Myotonic Dystrophy Type 1 Muscle Cells

(2013) Annalisa Botta et al.   Genes

Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart

(2012) E. Dale Abel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

GSK3β mediates muscle pathology in myotonic dystrophy

(2012) Karlie Jones et al.   JOURNAL OF CLINICAL INVESTIGATION

Microtubule network is required for insulin-induced signal transduction and actin remodeling

(2012) Li-Zhong Liu et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy

(2011) Charlotte Fugier et al.   NATURE MEDICINE

Obesity, insulin resistance and free fatty acids

(2011) Guenther Boden   Current Opinion in Endocrinology Diabetes and Obesity

Type 2 Myotonic Dystrophy Can Be Predicted by the Combination of Type 2 Muscle Fiber Central Nucleation and Scattered Atrophy

(2009) Guillaume Bassez et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2

(2009) Rosanna Cardani et al.   NEUROMUSCULAR DISORDERS

Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans

(2008) Sara Fröjdö et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2

(2008) Valerio Pisani et al.   MUSCLE & NERVE

Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1

(2008) William J. Groh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Signaling in Muscle Atrophy and Hypertrophy

(2008) Marco Sandri   PHYSIOLOGY